MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 17.02.2026
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Medizinische Instrumente |
Börse |
NYSESPB |
Anteile |
72.3 M |
Marktkapitalisierung |
$ 18.5 B |
EBITDA (LTM) |
$ 754 M |
P/E (LTM) |
37.34 |
P/S (LTM) |
6.15 |
EPS (LTM) |
6.87 |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
AtriCure
ATRC
|
$ 28.23 | 0.64 % | $ 1.35 B | Nasdaq Global Market,SPB | USA |
 |
Baxter International
BAX
|
$ 17.15 | -0.87 % | $ 8.8 B | NYSE,SPB | USA |
 |
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | USA |
 |
BioLife Solutions
BLFS
|
$ 19.74 | -3.61 % | $ 909 M | Nasdaq Global Select Market | USA |
 |
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | USA |
 |
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | USA |
 |
Alcon
ALC
|
$ 78.01 | 0.79 % | $ 40.4 B | NYSE |  Schweiz |
 |
Ekso Bionics Holdings
EKSO
|
- | - | $ 21.9 M | Nasdaq Capital Market | USA |
 |
The Cooper Companies
COO
|
$ 71.21 | -0.35 % | $ 14.2 B | NYSE,SPB | USA |
 |
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | USA |
 |
Haemonetics Corporation
HAE
|
$ 57.32 | -1.88 % | $ 2.88 B | NYSE,SPB | USA |
 |
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | USA |
 |
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | USA |
 |
Repro Med Systems
KRMD
|
$ 4.21 | -3.66 % | $ 194 M | Nasdaq Capital Market | USA |
 |
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | USA |
 |
Harvard Bioscience
HBIO
|
$ 4.31 | -19.74 % | $ 191 M | Nasdaq Global Market | USA |
 |
Microbot Medical
MBOT
|
$ 2.59 | 4.44 % | $ 119 M | Nasdaq Global Select Market |  Israel |
 |
electroCore
ECOR
|
$ 6.08 | -8.57 % | $ 51.6 K | Nasdaq Global Select Market | USA |
 |
Masimo Corporation
MASI
|
$ 178.32 | -0.01 % | $ 9.5 B | Nasdaq Global Select Market,SPB | USA |
 |
iRhythm Technologies
IRTC
|
- | - | $ 3.69 B | Nasdaq Global Select Market,SPB | USA |
 |
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | USA |
 |
Milestone Scientific
MLSS
|
$ 0.28 | 0.81 % | $ 23 M | NYSE American | USA |
 |
Merit Medical Systems
MMSI
|
$ 68.26 | -0.57 % | $ 4.04 B | Nasdaq Global Select Market,SPB | USA |
 |
Glaukos Corporation
GKOS
|
$ 116.4 | -2.55 % | $ 5.64 B | NYSE,SPB | USA |
 |
ICU Medical
ICUI
|
$ 125.68 | -0.12 % | $ 3.1 B | Nasdaq Global Select Market,SPB | USA |
 |
InfuSystem Holdings
INFU
|
$ 9.38 | -2.49 % | $ 194 M | NYSE American | USA |
 |
Envista Holdings Corporation
NVST
|
$ 26.39 | -1.05 % | $ 4.43 B | NYSE | USA |
 |
Pro-Dex
PDEX
|
$ 51.48 | 1.2 % | $ 169 M | Nasdaq Global Select Market | USA |
 |
Intuitive Surgical
ISRG
|
- | - | $ 161 B | Nasdaq Global Select Market,SPB | USA |
 |
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | USA |
 |
LeMaitre Vascular
LMAT
|
$ 114.62 | 1.69 % | $ 2.59 B | Nasdaq Global Market,SPB | USA |
 |
ResMed
RMD
|
$ 228.87 | 0.39 % | $ 33.4 B | NYSE,SPB | USA |
 |
Retractable Technologies
RVP
|
$ 0.67 | -6.67 % | $ 20.1 M | NYSE American | USA |
 |
Pulse Biosciences
PLSE
|
$ 18.67 | -3.01 % | $ 1.26 B | Nasdaq Global Select Market | USA |
 |
STERIS plc
STE
|
$ 222.58 | -0.52 % | $ 21.9 B | NYSE,SPB | USA |
 |
Stereotaxis
STXS
|
$ 1.87 | -4.1 % | $ 170 M | NYSE American | USA |
 |
Teleflex Incorporated
TFX
|
$ 118.39 | -1.56 % | $ 5.28 B | NYSE,SPB | USA |
 |
STAAR Surgical Company
STAA
|
$ 26.44 | 4.88 % | $ 1.31 B | Nasdaq Global Market,SPB | USA |
 |
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | USA |
 |
Utah Medical Products
UTMD
|
$ 65.9 | 1.6 % | $ 214 M | Nasdaq Global Select Market | USA |
 |
DENTSPLY SIRONA
XRAY
|
$ 11.71 | -1.26 % | $ 2.33 B | Nasdaq Global Select Market,SPB | USA |
 |
AngioDynamics
ANGO
|
$ 9.8 | -2.87 % | $ 400 M | Nasdaq Global Select Market | USA |
 |
Becton, Dickinson and Company
BDX
|
$ 154.22 | -0.77 % | $ 44.4 B | NYSE,SPB | USA |
 |
Nephros
NEPH
|
$ 2.96 | 1.72 % | $ 30.7 M | Nasdaq Global Select Market | USA |
 |
OraSure Technologies
OSUR
|
$ 2.96 | -3.27 % | $ 218 M | Nasdaq Global Select Market,SPB | USA |
 |
Repligen Corporation
RGEN
|
$ 120.1 | 0.27 % | $ 6.69 M | Nasdaq Global Select Market,SPB | USA |